Loading insider details...
Beta
Latest Form 4 (Aug 5, 2026): Sale of 2,447 ALMS shares, $64.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | ALUMIS INC. (ALMS) | Sale | 2,447 | $64.5K |
| May 27, 2026 | ALUMIS INC. (ALMS) | Exercise/Conversion | 11,317 | $100.0K |
| Jan 29, 2026 | ALUMIS INC. (ALMS) | Grant/Award | 221,450 | n/a |
| Aug 1, 2025 | ALUMIS INC. (ALMS) | Grant/Award | 25,450 | n/a |
| Feb 20, 2025 | ALUMIS INC. (ALMS) | Grant/Award | 180,000 | n/a |
| Jul 1, 2024 | ALUMIS INC. (ALMS) | Grant/Award | 5,347 | n/a |
| May 20, 2024 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Disposition to Issuer | 20,000 | n/a |
| Jan 4, 2024 | ALPINE IMMUNE SCIENCES, INC. (ALPN) | Grant/Award | 17,500 | n/a |
| Feb 4, 2022 | Ventyx Biosciences, Inc. (VTYX) | Grant/Award | 145,000 | n/a |